GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0734
0.00 (0.00%)
Oct 22, 2026, 5:35 PM CEST
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €17.21 million as of October 22, 2026. It is the 37,172nd most valuable company in the world and the 467th biggest in France. Its market cap has decreased by 24.52% in one year.
Market Cap
17.21M
Enterprise Value
28.38M
Revenue
-251.00K
Global Rank
Country Rank
#467 France
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 17.21M, a decrease of -93.17%. That is a compound annual growth rate of -22.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 17.21M | -25.22% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fermentalg | 36.65M |
| Nicox | 26.22M |
| MaaT Pharma | 20.69M |
| genOway Société anonyme | 20.28M |
| Biophytis | 11.41M |
| Poxel | 10.34M |
| TME Pharma | 10.22M |
| Aton | 10.10M |